These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

604 related items for PubMed ID: 9886882

  • 1. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY, Fedorova OV.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV, Bagrov AY.
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of two endogenous Na+,K(+)-ATPase inhibitors, marinobufagenin and ouabain, on isolated rat aorta.
    Bagrov AY, Roukoyatkina NI, Pinaev AG, Dmitrieva RI, Fedorova OV.
    Eur J Pharmacol; 1995 Feb 14; 274(1-3):151-8. PubMed ID: 7768267
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM.
    Am J Hypertens; 1996 Oct 14; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [Abstract] [Full Text] [Related]

  • 11. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV, Kolodkin NI, Agalakova NI, Lakatta EG, Bagrov AY.
    Hypertension; 2001 Feb 14; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [Abstract] [Full Text] [Related]

  • 12. Evidence that human endothelial cells express different isoforms of Na,K-ATPase.
    Mayol V, Dignat-George F, Gerbi A, Martin-Vasallo P, Lesaule G, Sampol J, Maixent JM.
    J Hypertens; 1998 Feb 14; 16(2):145-50. PubMed ID: 9535140
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Na+, K+-ATPase of the canine mesenteric artery.
    Wallick ET, Adams RJ, Fondacaro JD, Jacobson ED.
    Fed Proc; 1982 Apr 14; 41(6):2101-5. PubMed ID: 6281071
    [Abstract] [Full Text] [Related]

  • 15. [Role of the alpha2-isoform of Na+, K(+)-ATPase in the positive inotropic effect of ouabain and marinobufagenin in the rat diaphragm].
    Krivoĭ II, Drabkina TM, Kravtsova VV, Vasil'ev AN, Vashchinkina EV, Prokof'ev AV, Kubasov IV.
    Biofizika; 2006 Apr 14; 51(5):906-11. PubMed ID: 17131832
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
    Tao QF, Hollenberg NK, Graves SW.
    Hypertension; 1999 Nov 14; 34(5):1168-74. PubMed ID: 10567200
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.